Vyne Therapeutics Inc (VYNE) — Long-term Investment Intensity

Latest as of September 2019: 2.1%

Vyne Therapeutics Inc (VYNE) has a Long-term Investment Intensity of 2.1% as of September 2019. Long-term investments of $2.00 Million represent 2.1% of total assets of $96.58 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Vyne Therapeutics Inc book value and equity for net asset value and shareholders' equity analysis.

LT Investment Intensity

2.1%
LT Investments / Total Assets

Long-term Investments

$2.00 Million
USD

Total Assets

$96.58 Million
USD

Country

USA
NASDAQ

Vyne Therapeutics Inc Long-term Investment Intensity (2016–2017)

This chart shows how Vyne Therapeutics Inc's Long-term Investment Intensity has evolved across 2 annual periods from 2016 to 2017. As of September 2019, the intensity stands at 2.1%, reflecting long-term investments of $2.00 Million against total assets of $96.58 Million USD. Also explore Vyne Therapeutics Inc assets under control for the complete picture of this company's asset base.

Annual Long-term Investment Intensity for Vyne Therapeutics Inc (2016–2017)

The table below presents the year-by-year Long-term Investment Intensity for Vyne Therapeutics Inc from 2016 to 2017, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of Vyne Therapeutics Inc.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2017 4.5% $2.98 Million $66.87 Million ▼ -20.3 pp
2016 24.8% $10.42 Million $42.05 Million
pp = percentage points